XELLIA PHARMACEUTICALS
Caplin Point Labs' subsidiary inks distribution pact with Xellia Pharma for 5 injectables in USThe first product is expected to be launched shortly, while approvals for the remaining are expected in the next 12-18 months, Caplin Point...
EU regulators to fine Ranbaxy, Merck, others: SourcesThe European Union’s Anti-Trust Commission may impose a fine on Ranbaxy Labs among other generic and innovator firms, including Denmark-bas...
- Load More